Alk-Abello AS (CHIX:ALKBC) Other Stockholders Equity: kr-67 Mil (As of Mar. 2026)


CHIX:ALKBC Alk-Abello AS CHIX:ALKBC
92 GF Score
Price kr256.30
GF Value kr207.27
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Alk-Abello AS Other Stockholders Equity?

Alk-Abello AS CHIX:ALKBC 92 Other Stockholders Equity is kr-67 Mil as of Mar. 2026. GuruFocus rates CHIX:ALKBC with a GF Score™ of 92/100 and a GF Value™ of kr207.27 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Alk-Abello AS's Other Stockholders Equity for the quarter that ended in Mar. 2026 was kr-67 Mil.

Alk-Abello AS's quarterly Other Stockholders Equity increased from Sep. 2025 (kr-102 Mil) to Dec. 2025 (kr252 Mil) but then declined from Dec. 2025 (kr252 Mil) to Mar. 2026 (kr-67 Mil).

Alk-Abello AS's annual Other Stockholders Equity increased from Dec. 2023 (kr-18 Mil) to Dec. 2024 (kr65 Mil) and increased from Dec. 2024 (kr65 Mil) to Dec. 2025 (kr252 Mil).

Alk-Abello AS Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Alk-Abello AS's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alk-Abello AS Other Stockholders Equity Chart

Alk-Abello AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -41.00 20.00 -18.00 65.00 252.00

Alk-Abello AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.00 -100.00 -102.00 252.00 -67.00
CHIX:ALKBC
92GF Score
Alk-Abello AS CHIX:ALKBC
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alk-Abello AS Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of kr-67 Mil mean?
Alk-Abello AS (CHIX:ALKBC) has a Other Stockholders Equity of kr-67 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Alk-Abello AS and its competitors.
Is Alk-Abello AS's Other Stockholders Equity too high?
Alk-Abello AS's current Other Stockholders Equity is kr-67 Mil. Overall, Alk-Abello AS has a GF Score™ of 92/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alk-Abello AS's Other Stockholders Equity compare to VRTX and REGN?
Alk-Abello AS's Other Stockholders Equity of kr-67 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Alk-Abello AS and its competitors. Alk-Abello AS's current Other Stockholders Equity is kr-67 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alk-Abello AS stock overvalued right now?
Based on GuruFocus' analysis, Alk-Abello AS (CHIX:ALKBC) is currently considered Modestly Overvalued. The stock's GF Value™ is kr207.27, compared to a current price of kr256.30 — trading 23.7% above its estimated fair value. The current Other Stockholders Equity is kr-67 Mil. Alk-Abello AS's overall GF Score™ is 92/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Alk-Abello AS (CHIX:ALKBC), the current Other Stockholders Equity is kr-67 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alk-Abello AS (CHIX:ALKBC) Overvalued in 2026?

Based on GuruFocus' analysis, Alk-Abello AS stock appears to be overvalued. The current stock price of kr256.30 is trading 23.7% above its estimated GF Value™ of kr207.27. GuruFocus considers Alk-Abello AS to be Modestly Overvalued.

Key valuation signals for CHIX:ALKBC:

  • Other Stockholders Equity: kr-67 Mil
  • GF Value™: kr207.27 vs. price of kr256.30 (23.7% above fair value)
  • GF Score™: 92/100 with 5 warning signs

No single metric tells the full story. See the CHIX:ALKBC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alk-Abello AS Business Description

Address Boge Alle 6-8, Horsholm, DNK, DK-2970
Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication. The company operates in Europe, North America and International Markets. It derives maximum revenue from Europe.
92GF Score

Get the complete analysis for CHIX:ALKBC

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr256.30
Price
kr207.27
GF Value